The most important financial indicators for the company Lorydiab Med S.r.l. - Unique Identification Number 38987996:
sales in 2023 was
58.833
euro, registering a net profit of
34.987
euro and having an average number of
1
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 25.2%, from 47.135 euro in the year 2022, to 58.833 euro in 2023.
The Net Profit increased by 352 euro, from 34.740 euro in 2022, to 34.987 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Lorydiab Med S.r.l. - CUI 38987996
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
-
-
-
-
0
0
0
0
0
0
Current Assets
-
-
-
-
567
17.290
43.950
58.420
39.469
42.382
Inventories
-
-
-
-
0
324
283
440
0
0
Receivables
-
-
-
-
161
2.456
2.964
4.572
5.786
21.282
Cash
-
-
-
-
406
14.510
40.703
53.407
33.682
21.101
Shareholders Funds
-
-
-
-
-514
17.041
27.926
48.954
37.207
41.757
Social Capital
-
-
-
-
43
42
41
40
41
40
Debts
-
-
-
-
1.081
249
16.023
9.467
2.262
626
Income in Advance
-
-
-
-
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8622 - 8622"
CAEN Financial Year
8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
42.382 euro in 2023 which includes Inventories of
0 euro, Receivables of
21.282 euro and cash availability of
21.101 euro.
The company's Equity was valued at
41.757 euro, while total Liabilities amounted to
626 euro.
Equity increased by 4.662 euro, from 37.207 euro in 2022, to 41.757 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Lorydiab Med S.r.l.